📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CBT.
💹 Market Data
Market Cap$4.55B
Shares Outstanding51.62M
Float50.97M
Cash$253.00M
Debt$1.12B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 2.6% shares (2025Q4 vs prior)
360 institutional holders · 56.38M shares
#1
BlackRock, Inc.
6.62M shares
#2
VANGUARD GROUP INC
5.93M shares
#3
FULLER & THALER ASSET MANAGEMENT, INC.
4.69M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.84M
Days to Cover9.5
% of Float5.6%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
4
INSIDER TRANSACTION
Apr 01, 2026
4
INSIDER TRANSACTION
Mar 17, 2026
4
INSIDER TRANSACTION
Mar 17, 2026
4
INSIDER TRANSACTION
Mar 17, 2026
4
INSIDER TRANSACTION
Mar 17, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CBT
📊 CBT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CBT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.